National Screening Service
The Committee received an update paper on the National Screening Service Report which highlights the performance of screening services nationally.
The Committee reviewed with the Chief Executive of National Screening Service (NSS) the performance, priorities and challenges for each of the programmes, BreastCheck, CervicalCheck, BowelScreen and DiabeticRetina Screen.
BreastCheck
BreastCheck activity capacity is running at approximately 75%; with 10,560 mammograms carried out in January which is above target by 560 (5.6%), despite the continued impact of COVID-19 on capacity and staff absences.
BowelScreen
The BowelScreen programme screened 4,502 eligible participants in January which is 64% (7,998) below the target of 12,500. Invitations and completed screening tests continue to be impacted by the surge in COVID-19 infection rates. BowelScreen colonoscopy sites are scheduling appointments at reduced capacity due to the impact of COVID-19 on hospital capacity. Endoscopy services are not expected to operate at full capacity until at least April 2022. An additional Endoscopy Unit will be available to BowelScreen in Q1 2022.
CervicalCheck
The Committee were informed that CervicalCheck is fully operational, with 22,992 screening tests completed in January which is 22% below the target of 29,500.
CervicalCheck is working with colposcopy units and the National Women & Infants Health Programme to ensure sufficient capacity is available following the introduction of HPV testing and associated increase in referrals.
DiabeticRetina Screen
Diabetic RetinaScreen has staffing and uptake issues due to Covid-19. Diabetic RetinaScreen achieved a reduction in the number of times participants with the lowest risk of progression of retinopathy will be screened, by extending the screening interval for this cohort to two years. The programme continues to invite eligible participants to the new 2-yearly screening pathway. To date this is proving very successful with approximately 88% of participants remaining on this pathway.
The Chief Executive of the NSS informed the Committee that BreastCheck and BowelScreen continue to operate at least one year behind due to the pause in screening during 2020 and 2021 and the ongoing impact of COVID-19 and due to a global shortage of radiologists. The BreastCheck Radiology staffing levels are below optimum which impacts the programme’s ability to provided screening services.
The Committee discussed the challenges in recruitment noting there is global staff shortages. The Committee welcomed that a national review of radiology staffing has been requested by NSS & NCCP and initiated by the office of the CCO. The aim of this group is to explore short, medium and long-term options, look at training positions, education, and the promotion of breast radiology as a career option. In the immediate term, BreastCheck continue to actively recruit and aim to appoint consultants into vacancies across all four units.